Lung cancer is among the most common types of cancer diagnoses. Traditional radiation treatments for cancer take weeks or months, oftentimes with heavy side effects. Facing this can be emotionally daunting and time consuming. However, there is another answer.

CyberKnife has been delivering lung treatments in a non-invasive, effective way for 15 years, since it was first approved by the Food and Drug Administration as a viable treatment to cancerous and noncancerous tumors. Due to the advanced technology of CyberKnife Systems, the treatment is effective on all tumor types, even those too advanced for traditional surgery. A recent study comparing CyberKnife SABR to Surgery for “Operable” early-stage lung cancer shows a more favorable outcome to patients that had their lung tumors treated with CyberKnife.

CyberKnife treatments work by focusing radiation with pinpoint, sub-millimeter accuracy. The CyberKnife is unique in its ability to track and follow the lung tumor while the patient breathes naturally and treat with extreme precision. Because the treatment is so accurate, the exposure to the surrounding tissue is limited. Additionally, the treatments range from one to five sessions, with side effects minimal enough that patients are often able to go about their lives, even on their days of treatment. CyberKnife is the only technology in the world that offers real-time, tumor-tracking imaging, providing a level of accuracy that no other treatment option can achieve.

Guided by state-of-the-art robotic technology, the radiation can be delivered from almost any angle required, assisting in the most accurate and effective possible treatment. Using the advanced imaging and tumor-tracking software, CyberKnife offers another effective treatment in the fight back against cancer.